Literature DB >> 8753841

Eosinophil peroxidase deficiency in New Zealand white mice.

J Ohmori1, H Tokunaga, T Ezaki, H Maruyama, Y Nawa.   

Abstract

Eosinophil peroxidase (EPO) is one of the granule enzymes in the eosinophil-specific granules and is distinct from myeloperoxidase. Here we report that peroxidase activity was absent in eosinophils of New Zealand White (NZW) mice. When NZW, New Zealand Black and their F1 mice were treated with cyclophosphamide followed by Toxocara canis infection, the kinetic changes in the number of eosinophils in peripheral blood, determined by counting in Hinkelman's diluting fluid, were almost comparable among the three strains. However, when their blood films were stained for peroxidase reaction, eosinophils of NZW mice, but not of the other strains, lacked EPO activity, though their specific granules were stained by eosin Y. Sudan black staining for phospholipid was also negative in eosinophils of NZW mice. EPO deficiency in NZW eosinophils was further confirmed by electron-microscopic observations and by measuring EPO activity in the extracts of eosinophil-rich cell suspensions. These results indicate that NZW eosinophils share most of the features with human EPO-deficient eosinophils, suggesting that the NZW mouse is a murine counterpart of human EPO deficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753841     DOI: 10.1159/000237341

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  1 in total

1.  Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase.

Authors:  Martina Ulrich; Alina Petre; Nikolay Youhnovski; Franziska Prömm; Markus Schirle; Michael Schumm; Ralph S Pero; Alfred Doyle; James Checkel; Hirohito Kita; Nethaji Thiyagarajan; K Ravi Acharya; Peter Schmid-Grendelmeier; Hans-Uwe Simon; Heinz Schwarz; Masato Tsutsui; Hiroaki Shimokawa; Gabriel Bellon; James J Lee; Michael Przybylski; Gerd Döring
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.